FDA schedules Aimmune's peanut allergy drug for September expert review

Aimmune Therapeutics said Thursday the Food and Drug Administration's advisory committee on allergenic products will review its experimental peanut allergy pill in September, setting a date for an initial test of the growing allergy desensitization field.